Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Clinical trial NCT07431281 · RECRUITING
Trial details
- NCT number
- NCT07431281
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-03
- Primary completion
- 2029-08-16
- Enrollment
- 2130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.